Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: concern about this development

RE: concern about this development

posted on Aug 26, 2006 07:32PM
I think it still is ok. From ARMHY ``04 Report they are showing ``limitations of liability`` The largest being only $3mil. If these small limitations hold true with many of their licensees, I would think the licensee is then still on the hook in a big way. As well as for non ARM chip/tech.

By the way, for those looking to short ARMHY, it looks as though they are still in a share buyback mode and the limitations of their liabilities should be further explored. IMO.

http://sec.edgar-online.com/2004/06/21/0000950103-04-000868/Section16.asp

Share
New Message
Please login to post a reply